Cornelia Schiemann, LL.M.

Phone / Email
+49 451 31 70 260 - 0
CV       V-Card

Make appointment

Write an email
Make appointment
Visit LinkedIn Profile
Cornelia Schiemann, LL.M.

Cornelia Schiemann joined Wachenhausen Rechtsanwälte in September 2016. She focuses her practice on advising national and international pharmaceutical and medical devices companies on regulatory and compliance-related matters, particularly, concerning healthcare compliance and data privacy-related questions. In addition, Ms Schiemann regularly supports and represents clients before the German regulatory authorities regarding issues arising in connection with the implementation of clinical trials. She also provides regulatory advice in connection with the development of Advanced Therapy Medicinal Products (ATMPs) and orphan drugs. Before joining Wachenhausen Rechtsanwälte, Ms Schiemann was part of the European Life Sciences Practice at Sidley Austin LLP in Brussels, where she gained significant experience in advising international clients on anti-corruption and data privacy issues in connection with EU-U.S. cross-border investigations and in developing internal compliance processes, policies and procedures. During her time at Sidley Austin LLP, she also assisted clients in matters before the European courts. Ms Schiemann studied law at the European University Viadrina in Frankfurt (Oder) and the University of Kent at Brussels (BSIS). She completed her legal training at the District Court of Berlin, with stages at the Senate Chancellery of the federal state of Berlin and the German Consulate General in Edinburgh. Ms Schiemann also serves as an independent Ethics Expert for the European Commission in the evaluation of research projects funded under Horizon 2020. In addition, she is a member of the Committee “BioPharm” of the German Federal Association of the Pharmaceutical Industry (BPI). Ms Schiemann provides legal advice in German and in English.


Ms Schiemann focuses on:


Persönliches Mitglied bei Women in International Security e.V. (WiiS) Persönliches Mitglied des Ausschusses BioPharm des BPI Bundesverband der Pharmazeutischen Industrie e.V. (BPI) Kanzleimitgliedschaft Wachenhausen Rechtsanwälte INTEGRITAS Verein für lautere Heilmittelwerbung e.V. Kanzleimitgliedschaft Wachenhausen Rechtsanwälte Life Science Nord e.V. Kanzleimitgliedschaft Wachenhausen Rechtsanwälte Förderkreis der Forschungsstelle für Pharmarecht an der Philipps-Universität Marburg e.V. Kanzleimitgliedschaft Wachenhausen Rechtsanwälte


Die Einordnung datenschutzrechtlicher Verantwortlichkeiten am Beispiel der klinischen Prüfung

Cornelia Schiemann, LL.M.
A&R 2019, S. 147 ff. (zusammen mit Dr. Jens Peters und Ulf Zumdick)

Auswirkungen der Datenschutz-Grundverordnung auf den Umgang mit Pharmakovigilanz-Daten

Cornelia Schiemann, LL.M.
A&R 2018, S. 147 ff. (zusammen mit Dr. Monika Boos, LL.M.)

Nichtinterventionelle Studien in Deutschland – NIS

Cornelia Schiemann, LL.M.
in Hinze/Gleiter/Herbold (Hrsg.)
zusammen mit Prof. Dr. Heike Wachenhausen
Pharmind Serie Dokumentation, 1. Auflage 2018
ECV Editio Cantor Verlag